{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:05:09Z","timestamp":1781071509790,"version":"3.54.1"},"reference-count":81,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell Dev. Biol."],"abstract":"<jats:p>\n                    Radiotherapy is an essential component of multidisciplinary cancer treatment. Its role has expanded from conventional local tumor eradication to active regulation of the tumor immune microenvironment. In recent years, emerging radiotherapy strategies, including FLASH radiotherapy, boron neutron capture therapy, lattice radiotherapy, spatially fractionated radiation therapy, precision particle therapy, immunomodulatory stereotactic body radiotherapy, and immune-optimized carbon ion therapy, have provided new opportunities to improve tumor control, reduce normal tissue toxicity, and overcome radioresistance. Radiotherapy can induce DNA damage and immunogenic cell death, promote tumor antigen release, enhance dendritic cell maturation and antigen cross-presentation, and increase CD8\n                    <jats:sup>+<\/jats:sup>\n                    T-cell infiltration and antitumor immunity through the cGAS-STING type I interferon pathway. However, radiotherapy may also trigger immunosuppressive feedback, including the accumulation of myeloid-derived suppressor cells, tumor-associated macrophages, and regulatory T cells, as well as the upregulation of immune checkpoint molecules such as programmed death-ligand 1 (PD-L1). These changes may limit antitumor immune responses and contribute to radioresistance. Combining radiotherapy with immune checkpoint inhibitors can amplify antitumor immunity, but therapeutic efficacy is influenced by dose fractionation, treatment timing, tumor type, and baseline immune status. This mini review summarizes emerging radiotherapy strategies and their regulatory effects on the tumor immune microenvironment, and discusses the mechanistic basis, current challenges, and future directions of radiotherapy combined with immunotherapy.\n                  <\/jats:p>","DOI":"10.3389\/fcell.2026.1868063","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:39:33Z","timestamp":1781069973000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["The central role of radiotherapy in remodeling the tumor immune microenvironment: mechanisms and therapeutic implications"],"prefix":"10.3389","volume":"14","author":[{"given":"Zhipan","family":"Yi","sequence":"first","affiliation":[{"name":"Shaoyang Hospital for Maternal and Child Healthcare","place":["Shaoyang, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Chen","sequence":"additional","affiliation":[{"name":"Shaoyang Hospital for Maternal and Child Healthcare","place":["Shaoyang, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiulin","family":"Jiang","sequence":"additional","affiliation":[{"name":"College of Life Science, University of Chinese Academy of Sciences","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Hu","sequence":"additional","affiliation":[{"name":"Shaoyang Hospital for Maternal and Child Healthcare","place":["Shaoyang, Hunan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,6,10]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"5828","DOI":"10.1038\/sj.onc.1206681","article-title":"Functional genomics as a window on radiation stress signaling","volume":"22","author":"Amundson","year":"2003","journal-title":"Oncogene"},{"key":"B2","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1056\/nejmoa1709937","article-title":"Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"312","DOI":"10.21037\/apm.2018.07.10","article-title":"Immunotherapy and radiotherapy for metastatic cancers","volume":"8","author":"Bang","year":"2019","journal-title":"Ann. Palliative Med."},{"key":"B4","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.ccell.2024.07.010","article-title":"Long-lasting mRNA-encoded interleukin-2 restores CD8(+) T cell neoantigen immunity in MHC class I-deficient cancers","volume":"42","author":"Beck","year":"2024","journal-title":"Cancer Cell"},{"key":"B5","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1034\/j.1399-0039.2003.00020.x","article-title":"Total loss of MHC class I in colorectal tumors can be explained by two molecular pathways: beta2-microglobulin inactivation in MSI-positive tumors and LMP7\/TAP2 downregulation in MSI-negative tumors","volume":"61","author":"Cabrera","year":"2003","journal-title":"Tissue Antigens"},{"key":"B6","doi-asserted-by":"publisher","first-page":"116125","DOI":"10.1016\/j.intimp.2025.116125","article-title":"Lactate represses MHC-I antigen presentation via H4K5 lactylation-PRC2 in small cell lung cancer subtype A","volume":"170","author":"Cai","year":"2026","journal-title":"Int. Immunopharm."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2441","DOI":"10.3390\/ijms27052441","article-title":"Radiation-induced immune modulation and inflammatory responses in human cells and tissues","volume":"27","author":"Chen","year":"2026","journal-title":"Int. J. Mol. Sci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3390\/bios12020100","article-title":"Ion interference therapy of tumors based on inorganic nanoparticles","volume":"12","author":"Chi","year":"2022","journal-title":"Biosensors"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1056\/NEJMc1713349","article-title":"Recent developments in radiotherapy","volume":"377","author":"Citrin","year":"2017","journal-title":"N. Engl. J. Med."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1809","DOI":"10.1002\/med.21964","article-title":"Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment","volume":"43","author":"Coghi","year":"2023","journal-title":"Med. Res. Rev."},{"key":"B11","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41525-021-00200-0","article-title":"Radiosensitivity index emerges as a potential biomarker for combined radiotherapy and immunotherapy","volume":"6","author":"Dai","year":"2021","journal-title":"NPJ Genomic Med."},{"key":"B12","doi-asserted-by":"publisher","first-page":"101550","DOI":"10.1016\/j.xcrm.2024.101550","article-title":"Chemoradiotherapy-induced ACKR2(+) tumor cells drive CD8(+) T cell senescence and cervical cancer recurrence","volume":"5","author":"Dai","year":"2024","journal-title":"Cell. Reports. Med."},{"key":"B13","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.7150\/thno.101298","article-title":"Acylglycerol kinase inhibits macrophage anti-tumor activity via limiting mtDNA release and cGAS-STING-type I IFN response","volume":"15","author":"Du","year":"2025","journal-title":"Theranostics"},{"key":"B14","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/978-981-15-4272-5_25","article-title":"Autophagy and tumour radiotherapy","volume":"1207","author":"Gao","year":"2020","journal-title":"Adv. Exper. Med. Biol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"888713","DOI":"10.3389\/fimmu.2022.888713","article-title":"Shaping polarization of tumor-associated macrophages in cancer immunotherapy","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Immunol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"eabn6758","DOI":"10.1126\/scitranslmed.abn6758","article-title":"Radiation-induced circulating myeloid-derived suppressor cells induce systemic lymphopenia after chemoradiotherapy in patients with glioblastoma","volume":"15","author":"Ghosh","year":"2023","journal-title":"Sci. Translational Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ccell.2019.01.003","article-title":"Distinct immune cell populations define response to Anti-PD-1 monotherapy and Anti-PD-1\/Anti-CTLA-4 combined therapy","volume":"35","author":"Gide","year":"2019","journal-title":"Cancer Cell."},{"key":"B18","doi-asserted-by":"publisher","first-page":"104682","DOI":"10.1016\/j.canrad.2025.104682","article-title":"Radiotherapy: beyond cancer","volume":"29","author":"Giraud","year":"2025","journal-title":"Cancer radiotherapie J. de la Soc. francaise de radiotherapie Oncol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e007847","DOI":"10.1136\/jitc-2023-007847","article-title":"High-dimensional single-cell proteomics analysis of esophageal squamous cell carcinoma reveals dynamic alterations of the tumor immune microenvironment after neoadjuvant therapy","volume":"11","author":"Han","year":"2023","journal-title":"J. Immun. Cancer"},{"key":"B20","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1158\/2159-8290.cd-21-0003","article-title":"Low-dose radiotherapy reverses tumor immune desertification and resistance to immunotherapy","volume":"12","author":"Herrera","year":"2022","journal-title":"Cancer Discovery"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1945","DOI":"10.1158\/1078-0432.ccr-23-3206","article-title":"Radiotherapy enhances metastasis through immune suppression by inducing PD-L1 and MDSC in distal sites","volume":"30","author":"Hou","year":"2024","journal-title":"Clin. Cancer Res. An Official J. Am. Assoc. Cancer Res."},{"key":"B22","doi-asserted-by":"publisher","first-page":"eabl9330","DOI":"10.1126\/sciimmunol.abl9330","article-title":"ATR-mediated CD47 and PD-L1 up-regulation restricts radiotherapy-induced immune priming and abscopal responses in colorectal cancer","volume":"7","author":"Hsieh","year":"2022","journal-title":"Sci. Immunol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3892\/mco.2025.2818","article-title":"Ultra-high dose rate (FLASH) treatment: a novel radiotherapy modality","volume":"22","author":"Huang","year":"2025","journal-title":"Mol. Clinical Oncol."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186492","article-title":"FLASH radiotherapy: current knowledge and future insights using proton-beam therapy","volume":"21","author":"Hughes","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20133212","article-title":"Tumor microenvironment as A \u201cGame Changer\u201d in cancer radiotherapy","volume":"20","author":"Jarosz-Biej","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000826","article-title":"Combination of radiotherapy and suppression of tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer","volume":"8","author":"Ji","year":"2020","journal-title":"J. Immun. Cancer"},{"key":"B27","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/hp.0000000000001601","article-title":"Radiation-induced cell death and its mechanisms","volume":"123","author":"Jiao","year":"2022","journal-title":"Health Phys."},{"key":"B28","doi-asserted-by":"publisher","first-page":"104298","DOI":"10.1016\/j.cellimm.2021.104298","article-title":"Radiotherapy and cGAS\/STING signaling: impact on MDSCs in the tumor microenvironment","volume":"362","author":"Kho","year":"2021","journal-title":"Cell. Immunol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"153093","DOI":"10.1016\/j.bbrc.2025.153093","article-title":"Dual PI3K\u03b4\/\u03b3 inhibition enhances radiotherapy-induced antitumor immunity via macrophage-dependent cGAS-STING-type I interferon signaling","volume":"795","author":"Kim","year":"2026","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"B30","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.21037\/cco.2017.06.30","article-title":"Stereotactic body radiotherapy for primary renal cell carcinoma and adrenal metastases","volume":"6","author":"Kothari","year":"2017","journal-title":"Chin. Clinical Oncology"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1038\/s41416-023-02459-9","article-title":"Preoperative chemoradiotherapy induces multiple pathways related to anti-tumour immunity in rectal cancer","volume":"129","author":"Koukourakis","year":"2023","journal-title":"Br. J. Cancer"},{"key":"B32","doi-asserted-by":"publisher","first-page":"2081","DOI":"10.3390\/biomedicines11072081","article-title":"Tumor-associated macrophages affect the tumor microenvironment and radioresistance via the upregulation of CXCL6\/CXCR2 in hepatocellular carcinoma","volume":"11","author":"Lee","year":"2023","journal-title":"Biomed."},{"key":"B33","doi-asserted-by":"publisher","first-page":"oyae344","DOI":"10.1093\/oncolo\/oyae344","article-title":"Plasma ctDNA kinetics as a predictor of systemic therapy response for advanced non-small cell lung cancer: a systematic review and meta-analysis","volume":"30","author":"Leite da Silva","year":"2025","journal-title":"Oncologist"},{"key":"B34","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1038\/s41392-021-00670-9","article-title":"Myeloid-derived suppressor cells as immunosuppressive regulators and therapeutic targets in cancer","volume":"6","author":"Li","year":"2021","journal-title":"Signal Transduction Targeted Therapy"},{"key":"B35","doi-asserted-by":"publisher","first-page":"7709","DOI":"10.1038\/s41467-023-43462-1","article-title":"Low-dose radiotherapy combined with dual PD-L1 and VEGFA blockade elicits antitumor response in hepatocellular carcinoma mediated by activated intratumoral CD8(+) exhausted-like T cells","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"B36","doi-asserted-by":"publisher","first-page":"2307","DOI":"10.1136\/gutjnl-2022-329147","article-title":"Targeting MS4A4A on tumour-associated macrophages restores CD8+ T-cell-mediated antitumour immunity","volume":"72","author":"Li","year":"2023","journal-title":"Gut"},{"key":"B37","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/j.ijrobp.2023.12.013","article-title":"Overview and recommendations for prospective multi-institutional spatially fractionated radiation therapy clinical trials","volume":"119","author":"Li","year":"2024","journal-title":"Int. J. Radiation Oncol. Biol. Phys."},{"key":"B38","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41392-025-02184-0","article-title":"Ultra-high dose rate radiotherapy overcomes radioresistance in head and neck squamous cell carcinoma","volume":"10","author":"Li","year":"","journal-title":"Signal Transduction Targeted Therapy"},{"key":"B39","doi-asserted-by":"publisher","first-page":"102235","DOI":"10.1016\/j.xcrm.2025.102235","article-title":"RANKL\/PD-1 dual blockade demonstrates survival benefit for patients with advanced lung adenocarcinoma harboring KRAS mutations","volume":"6","author":"Li","year":"","journal-title":"Cell. Reports. Med."},{"key":"B40","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/s40425-019-0692-z","article-title":"Local and abscopal responses in advanced intrahepatic cholangiocarcinoma with low TMB, MSS, pMMR and negative PD-L1 expression following combined therapy of SBRT with PD-1 blockade","volume":"7","author":"Liu","year":"2019","journal-title":"J. Immun. Cancer"},{"key":"B41","doi-asserted-by":"publisher","first-page":"809761","DOI":"10.3389\/fimmu.2022.809761","article-title":"A new trend in cancer treatment: the combination of epigenetics and immunotherapy","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Immunol."},{"key":"B42","doi-asserted-by":"publisher","first-page":"e2201401","DOI":"10.1002\/smtd.202201401","article-title":"Radiation-induced immunogenic cell death for cancer radioimmunotherapy","volume":"7","author":"Liu","year":"2023","journal-title":"Small Methods"},{"key":"B43","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/s41419-023-06211-2","article-title":"Radiotherapy remodels the tumor microenvironment for enhancing immunotherapeutic sensitivity","volume":"14","author":"Liu","year":"2023","journal-title":"Cell. Death Dis."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e01819","DOI":"10.1002\/advs.202501819","article-title":"Bispecific antibody targeting VEGF\/TGF-\u03b2 synergizes with local radiotherapy: turning tumors from cold to inflamed and amplifying abscopal effects","volume":"12","author":"Lyu","year":"2025","journal-title":"Adv. Sci. Weinheim, Baden-Wurttemberg, Ger."},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ac65d3","article-title":"Roadmap: helium ion therapy","volume":"67","author":"Mairani","year":"2022","journal-title":"Phys. Med. Biol."},{"key":"B46","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1038\/nrclinonc.2016.217","article-title":"Tumour-associated macrophages as treatment targets in oncology","volume":"14","author":"Mantovani","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41568-020-0246-1","article-title":"Inflammatory microenvironment remodelling by tumour cells after radiotherapy","volume":"20","author":"McLaughlin","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"B48","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.semradonc.2024.04.002","article-title":"Spatially fractionated radiotherapy in the era of immunotherapy","volume":"34","author":"McMillan","year":"2024","journal-title":"Seminars Radiation Oncology"},{"key":"B49","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1016\/j.semradonc.2024.05.001","article-title":"Democratizing FLASH radiotherapy","volume":"34","author":"Moreau","year":"2024","journal-title":"Seminars Radiation Oncol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/lary.30761","article-title":"Loss of human leukocyte antigen and immune escape in head and neck cancer","volume":"134","author":"Morris","year":"2024","journal-title":"Laryngoscope"},{"key":"B51","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1002\/pro6.1248","article-title":"Feasibility planning study of lattice radiotherapy for palliation in bulky tumors","volume":"8","author":"Np","year":"2024","journal-title":"Precis. Radiation Oncol."},{"key":"B52","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1038\/s41586-025-08994-0","article-title":"Radiation-induced amphiregulin drives tumour metastasis","volume":"643","author":"Piffk\u00f3","year":"2025","journal-title":"Nature"},{"key":"B53","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1016\/j.ccell.2023.04.001","article-title":"Simultaneous targeting of PD-1 and IL-2R\u03b2\u03b3 with radiation therapy inhibits pancreatic cancer growth and metastasis","volume":"41","author":"Piper","year":"2023","journal-title":"Cancer Cell."},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6560\/ad4192","article-title":"Spatially fractionated radiation therapy: a critical review on current status of clinical and preclinical studies and knowledge gaps","volume":"69","author":"Prezado","year":"2024","journal-title":"Phys. Med. Biol."},{"key":"B55","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s12943-025-02276-z","article-title":"IL-4 mediated TAP2 downregulation is a dominant and reversible mechanism of immune evasion and immunotherapy resistance in non-small cell lung cancer","volume":"24","author":"Ranjan","year":"2025","journal-title":"Mol. Canc."},{"key":"B56","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1136\/gutjnl-2024-333492","article-title":"Induction of macrophage efferocytosis in pancreatic cancer via PI3K\u03b3 inhibition and radiotherapy promotes tumour control","volume":"74","author":"Russell","year":"2025","journal-title":"Gut"},{"key":"B57","doi-asserted-by":"publisher","first-page":"20200183","DOI":"10.1259\/bjr.20200183","article-title":"Particle therapy in the future of precision therapy","volume":"93","author":"Schaub","year":"2020","journal-title":"Br. J. Radiol."},{"key":"B58","doi-asserted-by":"publisher","first-page":"e007068","DOI":"10.1136\/jitc-2023-007068","article-title":"Discovery of a novel dual-targeting D-peptide to block CD24\/Siglec-10 and PD-1\/PD-L1 interaction and synergize with radiotherapy for cancer immunotherapy","volume":"11","author":"Shen","year":"2023","journal-title":"J. Immunotherapy Cancer"},{"key":"B59","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1007\/s00428-023-03568-9","article-title":"MHC class I loss is associated with biliary\/progenitor cell features and \u201ccold\u201d tumor-immune microenvironment in hepatocellular carcinoma","volume":"483","author":"Shigematsu","year":"2023","journal-title":"Virchows Archiv. Intern. J. Pathol."},{"key":"B60","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1038\/s41418-025-01457-z","article-title":"STING directly interacts with PAR to promote apoptosis upon acute ionizing radiation-mediated DNA damage","volume":"32","author":"Sun","year":"2025","journal-title":"Cell. Death Differentiation"},{"key":"B61","doi-asserted-by":"publisher","first-page":"e20231717","DOI":"10.1084\/jem.20231717","article-title":"CD301b+ monocyte-derived dendritic cells mediate resistance to radiotherapy","volume":"222","author":"Tadepalli","year":"2025","journal-title":"J. Experimental Medicine"},{"key":"B62","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1111\/iju.14855","article-title":"Boron neutron capture therapy for urological cancers","volume":"29","author":"Takahara","year":"2022","journal-title":"Int. J. Urol. Official J. Jpn. Urological Assoc."},{"key":"B63","doi-asserted-by":"publisher","first-page":"2497","DOI":"10.1056\/NEJMoa1912388","article-title":"Efficacy and safety of low-dose colchicine after myocardial infarction","volume":"381","author":"Tardif","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1038\/s43018-024-00775-4","article-title":"Tumor-associated macrophages restrict CD8(+) T cell function through collagen deposition and metabolic reprogramming of the breast cancer microenvironment","volume":"5","author":"Tharp","year":"2024","journal-title":"Nat. Cancer"},{"key":"B65","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1038\/s43018-023-00547-6","article-title":"CD103(+) regulatory T cells underlie resistance to radio-immunotherapy and impair CD8(+) T cell activation in glioblastoma","volume":"4","author":"van Hooren","year":"2023","journal-title":"Nat. Cancer"},{"key":"B66","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/s0140-6736(24)02319-5","article-title":"Radiotherapy toxicities: mechanisms, management, and future directions","volume":"405","author":"Verginadis","year":"2025","journal-title":"Lancet London, Engl."},{"key":"B67","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1038\/s41571-022-00697-z","article-title":"Towards clinical translation of FLASH radiotherapy","volume":"19","author":"Vozenin","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.ccell.2023.04.019","article-title":"YTHDF2 inhibition potentiates radiotherapy antitumor efficacy","volume":"41","author":"Wang","year":"","journal-title":"Cancer Cell."},{"key":"B69","doi-asserted-by":"publisher","first-page":"e006235","DOI":"10.1136\/jitc-2022-006235","article-title":"Adding liposomal doxorubicin enhances the abscopal effect induced by radiation\/\u03b1PD1 therapy depending on tumor cell mitochondrial DNA and cGAS\/STING","volume":"11","author":"Wang","year":"","journal-title":"J. Immunotherapy Cancer"},{"key":"B70","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1007\/s00262-023-03379-6","article-title":"Radiotherapy enhances CXCR3(high)CD8(+) T cell activation through inducing IFN\u03b3-mediated CXCL10 and ICAM-1 expression in lung cancer cells","volume":"72","author":"Wang","year":"2023","journal-title":"Cancer Immunol. Immunotherapy CII"},{"key":"B71","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/s41419-024-06638-1","article-title":"STING agonist diABZI enhances the cytotoxicity of T cell towards cancer cells","volume":"15","author":"Wang","year":"2024","journal-title":"Cell. Death and Disease"},{"key":"B72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3892\/ijmm.2025.5708","article-title":"HMGB1 mediates low-dose ionizing radiation-induced Wnt\/\u03b2-catenin activation in SRA01\/04 cells: mechanistic clues to early cataractogenesis","volume":"57","author":"Wang","year":"2026","journal-title":"Int. J. Mol. Med."},{"key":"B73","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1667\/RADE-20-00066.1","article-title":"The technical and clinical implementation of LATTICE radiation therapy (LRT)","volume":"194","author":"Wu","year":"2020","journal-title":"Radiat. Res."},{"key":"B74","doi-asserted-by":"publisher","first-page":"52","DOI":"10.20892\/j.issn.2095-3941.2020.0400","article-title":"Updating targets for natural killer\/T-cell lymphoma immunotherapy","volume":"18","author":"Xue","year":"2021","journal-title":"Cancer Biol. and Med."},{"key":"B75","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s12916-024-03257-7","article-title":"Genomic characterization and immunotherapy for microsatellite instability-high in cholangiocarcinoma","volume":"22","author":"Yang","year":"2024","journal-title":"BMC Medicine"},{"key":"B76","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1038\/s41591-020-1131-x","article-title":"Liver metastasis restrains immunotherapy efficacy via macrophage-mediated T cell elimination","volume":"27","author":"Yu","year":"2021","journal-title":"Nat. Medicine"},{"key":"B77","doi-asserted-by":"publisher","first-page":"e2114851119","DOI":"10.1073\/pnas.2114851119","article-title":"D-mannose facilitates immunotherapy and radiotherapy of triple-negative breast cancer via degradation of PD-L1","volume":"119","author":"Zhang","year":"2022","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"B78","doi-asserted-by":"publisher","first-page":"101151","DOI":"10.1016\/j.xcrm.2023.101151","article-title":"CD39 inhibition and VISTA blockade may overcome radiotherapy resistance by targeting exhausted CD8+ T cells and immunosuppressive myeloid cells","volume":"4","author":"Zhang","year":"2023","journal-title":"Cell. Reports. Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12943-023-01725-x","article-title":"Roles of tumor-associated macrophages in anti-PD-1\/PD-L1 immunotherapy for solid cancers","volume":"22","author":"Zhang","year":"2023","journal-title":"Mol. Cancer"},{"key":"B81","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/j.ijrobp.2023.02.013","article-title":"Single high-dose irradiation-induced iRhom2 upregulation promotes macrophage antitumor activity through cGAS\/STING signaling","volume":"116","author":"Zhao","year":"2023","journal-title":"Int. J. Radiation Oncol. Biol. Phys."},{"key":"B82","doi-asserted-by":"publisher","first-page":"e02876","DOI":"10.1002\/advs.202502876","article-title":"A nanomodulator enhances radiotherapy-induced in situ cancer vaccine by promoting antigen-presenting of tumor-associated macrophage","volume":"12","author":"Zhao","year":"2025","journal-title":"Adv. Science Weinheim, Baden-Wurttemberg, Ger."}],"container-title":["Frontiers in Cell and Developmental Biology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1868063\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T05:39:34Z","timestamp":1781069974000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcell.2026.1868063\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,10]]},"references-count":81,"alternative-id":["10.3389\/fcell.2026.1868063"],"URL":"https:\/\/doi.org\/10.3389\/fcell.2026.1868063","relation":{},"ISSN":["2296-634X"],"issn-type":[{"value":"2296-634X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,10]]},"article-number":"1868063"}}